Trending...
- Massachusetts: Baker-Polito Administration Launches COVID-19 Vaccine CDC Pharmacy Partnership - Phase 1, Expands Vaccine Locations & Names Fenway Park as Mass Vaccination Site
- Boston: A message from Commissioner McCosh: Inauguration event accessibility
- Former US Deputy Assistant Secretary of Defense Dr. Joe Felter joins 6K's Advisory Board
The hair loss treatment experts at Premier Dermatology discuss topical hair restoration medications and their efficacy.
WELLESLEY, Mass. - BostonChron -- Millions of men and women around the world experience varying levels of hair loss at different stages of their lives. While there are several non-invasive oral and topical treatment options available, these do not stop hair loss or regrow hair in everyone. Premier Dermatology, a Wellesley dermatologist offering cosmetic and medical hair restoration solutions, offers helpful information about topical and oral hair restoration products and how they work.
Minoxidil is the medication found in over-the-counter (and some prescription) topical hair restoration products, which are typically sold as shampoos, liquids and foams. It is an FDA-approved medication and has been shown to stimulate hair growth for both men and women and is currently the only FDA approved treatment for female pattern hair loss in women. It works by dilating (opening up) blood vessels in the scalp, increasing blood flow (and nutrients) to hair follicles. Minoxidil is known by a few different brand names and is available in 2% and 5% strengths. Recently, some providers have begun prescribing low doses of oral minoxidil to encourage hair regrowth in females. Although many individuals may find this more convenient than topical therapy, additional data and larger studies to establish both efficacy and safety are needed before adopting this as an oral treatment.
More on Boston Chron
Finasteride is a medication that is most commonly prescribed to men who have hair loss or an enlarged prostate. It works by blocking the conversion of testosterone into dihydrotestosterone (DHT) and DHT is the hormone responsible for male pattern hair loss. For hair loss, pre-clinical trials did not show efficacy in women at the 1mg daily dose; however, there is some literature on the use of a 5mg daily dose of finasteride in the treatment of female pattern hair loss. This treatment is mostly reserved for post-menopausal women or women with specific hormone imbalances because finasteride is a known teratogen. This means that if a pregnant woman takes finasteride there may be abnormal sexual development of a male fetus/infant.
On the Horizon: Dutasteride.
Dutasteride is also a 5 alpha-1 reductase inhibitor that is FDA approved for treatment of enlarged prostate, but not for treatment of male pattern hair loss in the United States. In Asia it is sold as Avodart and is prescribed more commonly than finasteride for hair restoration. Both finasteride and Dutasteride have the same mechanism of action; however, Dutasteride appears to be a more powerful inhibitor of the testosterone to DHT conversion at lower doses, making it a potentially more effective treatment.
More on Boston Chron
Click here to learn more - https://premierderm.org/
Minoxidil is the medication found in over-the-counter (and some prescription) topical hair restoration products, which are typically sold as shampoos, liquids and foams. It is an FDA-approved medication and has been shown to stimulate hair growth for both men and women and is currently the only FDA approved treatment for female pattern hair loss in women. It works by dilating (opening up) blood vessels in the scalp, increasing blood flow (and nutrients) to hair follicles. Minoxidil is known by a few different brand names and is available in 2% and 5% strengths. Recently, some providers have begun prescribing low doses of oral minoxidil to encourage hair regrowth in females. Although many individuals may find this more convenient than topical therapy, additional data and larger studies to establish both efficacy and safety are needed before adopting this as an oral treatment.
More on Boston Chron
- Congressional Medal of Honor Society will host 2021 convention in Boston
- Boston: Update on the Ronan Park Well
- Avery Design Announces CXL™ 2.0 VIP
- Nova Biomedical FLEX2 Cell Culture Analyzer Adds Sample Retain Capability
- Kaizen Finance Launches Staking to Foster the Widespread Adoption of DeFi
Finasteride is a medication that is most commonly prescribed to men who have hair loss or an enlarged prostate. It works by blocking the conversion of testosterone into dihydrotestosterone (DHT) and DHT is the hormone responsible for male pattern hair loss. For hair loss, pre-clinical trials did not show efficacy in women at the 1mg daily dose; however, there is some literature on the use of a 5mg daily dose of finasteride in the treatment of female pattern hair loss. This treatment is mostly reserved for post-menopausal women or women with specific hormone imbalances because finasteride is a known teratogen. This means that if a pregnant woman takes finasteride there may be abnormal sexual development of a male fetus/infant.
On the Horizon: Dutasteride.
Dutasteride is also a 5 alpha-1 reductase inhibitor that is FDA approved for treatment of enlarged prostate, but not for treatment of male pattern hair loss in the United States. In Asia it is sold as Avodart and is prescribed more commonly than finasteride for hair restoration. Both finasteride and Dutasteride have the same mechanism of action; however, Dutasteride appears to be a more powerful inhibitor of the testosterone to DHT conversion at lower doses, making it a potentially more effective treatment.
More on Boston Chron
- Ismail Sirdah Describes the Best Practices for Holding Corporate Events
- MDAdvantage Appoints Pete Cammarano to Board of Directors
- CEO Coaching International Congratulates Client Orion Energy on Successful Capital Partnerships
- expEDIum Direct Pay®, seamless online payment added to iTech's expEDIum Medical Billing®
- Office Properties Income Trust Fourth Quarter 2020 Conference Call Scheduled for Friday, February 19th
Click here to learn more - https://premierderm.org/
Source: Premier Dermatology
0 Comments
Latest on Boston Chron
- Pro Golfer Kamaiu Johnson Joins Cambridge Mobile Telematics as Brand Ambassador
- Empirix Helps CEHE Confidently Migrate to Five9 Cloud-Based Contact Center Software USA - English USA - English
- Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
- Manulife Investment Management announces new managing director of institutional distribution, southeast region
- Boston: Meet some of this year's Opportunity Fund grantees
- City Streaming TV, a Streaming Television Inc Network Launches, bringing Community and Faith Leaders into local TV's, At No Cost
- Perini Management Services, Inc. Announces Two Federal Contracts Collectively Valued at $66.9 Million
- "GLORY of HISTORY" Hip-Hop Music Video Looks At Voter's Choice
- BoatDealers.ca Surges with Record Traffic in 2020
- CoVerified Announces Partnership with Mirimus for Nationwide K-12 Pooled Saliva COVID-19 Testing Program
- Reify Health Announces Global Expansion of StudyTeam to Over 2,700 Clinical Research Sites
- 'Aesthetic Institute of Massachusetts' Announces Rebranding to 'Aesthetic Mentor'
- OCC Adopts Final Rule Requiring Large Banks to Provide Fair Access to Banking Services
- New GCI Study On Gynecologic Cancers in Brazil Finds Most Patients Present With Advanced Disease
- The Antenna Company Announces Venture Debt Financing Agreement with Brabant Development Agency (BOM)
- Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
- Cohere Capital Completes Strategic Growth Investment in CCS, a Leading Digital Brand and E-Commerce Retailer
- Syros Announces Pricing of $75.6 Million Public Offering of Common Stock
- Code18 Interactive Launches New Websites for Balmex and Balmex Adult
- LabMinds Successfully Receives Approval for Use in a GMP Certified Laboratory.